企業プロフィール
Avadel 株価・ニュース・カタリスト
- ティッカー:
- AVDL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Ireland
株価変動の要因
Current closing-price context is not available for AVDL.
企業概要
事業概要
Avadel Pharmaceuticals is a specialty pharmaceutical company focused on sleep medicine, especially narcolepsy-related treatment. Its business is built around a commercial product with ongoing launch and market-expansion opportunities.
所在地とセクター分類
Avadel is headquartered in Ireland and listed on NASDAQ. It sits in specialty pharma and sleep medicine.
ビジネスモデルの特徴
The company depends on product adoption, access, and the ability to grow a focused commercial franchise. Investors watch revenue, payer coverage, and label or market expansion.
バイオ業界での位置付け
Avadel occupies a specialty-sleep niche within pharma. It is more commercial than development-stage biotech, but the stock still responds to launch execution and market access.
今後のカタリスト
- Avadel’s catalysts are LUMRYZ commercialization and any label or market-expansion step that strengthens the sleep-franchise story. The company’s value is tied to whether the launch keeps scaling.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。